Developer docs
API playgroundTry for free, no card

Search company profiles

Hopen Life Science Ventures

Full company profile

uuid000eitq

Namestring
Hopen Life Science Ventures
Websiteurl
hopenls.com
Company typeenum
Private
Founded yearint
2008
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGrand Rapids, United States
HQ citystring
Grand Rapids
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
venture capital, life science investments, healthcare venture capital, biotech investments, early-stage funding
Industry3 codes
1Early-Stage Venture Capital (Pre-Seed/Seed)
CodeFSANAAAAPrimaryYes
2Healthcare & Life Sciences Growth Equity
CodeFSANACABPrimaryNo
3Healthcare Access & Life Sciences Impact Funds
CodeFSANAJAIPrimaryNo
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • All Other Financial Investment Activities52399
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Life Science Investment
No data
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Hopen Life Science Ventures is described as a venture capital firm investing in the life science and healthcare sectors. However, its public website is currently in a "Launching Soon" pre-launch state, with no fund products, portfolio, or investment vehicles currently listed or marketed. The site only offers a contact form for email list sign-ups.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Hopen Life Science Ventures is a life science company that appears to be in pre-launch stage. The website displays a "Launching Soon" placeholder page with no product or service offerings currently visible. The company maintains a contact form for email list sign-ups but has not yet announced any products, platforms, or services.

Product and service1 record
1Email List Sign-Up
CategoryMarketing / Lead Capture
Description

A contact/email signup form on the company's website allowing interested parties to join an email list for updates, promotions, and more.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Early-stage venture firm focused on life sciences, including biotech and platform technologies. Comparable as an early-stage life-sciences specialist in the same category as Hopen.

TypeDirect peer
Description

Healthcare-dedicated venture firm investing across biotech, medical devices, and diagnostics. Directly comparable vertical focus to Hopen, with a much larger team and multiple funds.

TypeDirect peer
Description

Biotechnology-focused innovation platform that creates and funds life-sciences companies. Comparable as a deep life-sciences specialist, though operating at vastly greater scale with proprietary company-creation model.

TypeDirect peer
Description

Early-stage life sciences venture firm that builds biotech companies from inception. Comparable as an early-stage specialist in the same life-sciences category Hopen targets.

TypeDirect peer
Description

Biotech-focused venture firm investing across oncology and other therapeutic areas. Directly comparable life-sciences specialist, though significantly larger and more institutional.

TypeRegional player
Description

Regional life-sciences commercialization organization supporting healthcare and biotech startups in the Midwest. Compares as a regionally focused life-sciences ecosystem participant, though structured more as a support organization than a pure VC.

TypeDirect peer
Description

Healthcare-dedicated investment firm across venture, growth, and credit stages. Closely comparable sector focus on life sciences and healthcare, with far broader scale and product offerings.

TypeBroad incumbent
Description

Large healthcare investment firm spanning venture, public equities, and credit. Broad incumbent in the healthcare investment space Hopen targets, with overlapping life-sciences venture activity but a much wider mandate.

TypeDirect peer
Description

One of the most established US venture firms focused exclusively on life sciences and advanced technology, including biotech and healthcare. Highly comparable as a specialist life-sciences investor, though significantly larger and more established than Hopen.

TypeDirect peer
Description

Healthcare-focused venture and growth firm investing across biopharma and medical devices. Same sector thesis as Hopen, with a multi-fund platform and longer operating history.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment12 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hopen Life Science Ventures

Venture Capital / Life Science Investmenthopenls.com

Hopen Life Science Ventures firmographics

Firmographics
Name
Hopen Life Science Ventures
Website
https://hopenls.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Hopen Life Science Ventures industry classification

Industry
Product category
Venture Capital / Life Science Investment
NAICS
Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)
SIC
Investment Advice (6282)
akta.pro primary industry
Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)
akta.pro secondary industries
Healthcare & Life Sciences Growth Equity (FSANACAB), Healthcare Access & Life Sciences Impact Funds (FSANAJAI)

Keywords

  • Venture capital
  • Life science investments
  • Healthcare venture capital
  • Biotech investments
  • Early-stage funding

Where Hopen Life Science Ventures is headquartered

Location

Headquarters

HQ city
Grand Rapids
HQ country
United States
HQ region
North America

Markets served

Hopen Life Science Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

Hopen Life Science Ventures product offering

Product offering

Core offering

Hopen Life Science Ventures is described as a venture capital firm investing in the life science and healthcare sectors. However, its public website is currently in a "Launching Soon" pre-launch state, with no fund products, portfolio, or investment vehicles currently listed or marketed. The site only offers a contact form for email list sign-ups.

Product overview

Hopen Life Science Ventures is a life science company that appears to be in pre-launch stage. The website displays a "Launching Soon" placeholder page with no product or service offerings currently visible. The company maintains a contact form for email list sign-ups but has not yet announced any products, platforms, or services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Email List Sign-Up A contact/email signup form on the company's website allowing interested parties to join an email list for updates, promotions, and more.

Companies that use Hopen Life Science Ventures

Customer profile

Ideal customer profiles1 record

Hopen Life Science Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hopen Life Science Ventures partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

Hopen Life Science Ventures competitors and assessment

Company assessment

Direct peers

  • 5AM Ventures: Early-stage venture firm focused on life sciences, including biotech and platform technologies. Comparable as an early-stage life-sciences specialist in the same category as Hopen.
  • Versant Ventures: Healthcare-dedicated venture firm investing across biotech, medical devices, and diagnostics. Directly comparable vertical focus to Hopen, with a much larger team and multiple funds.
  • Flagship Pioneering: Biotechnology-focused innovation platform that creates and funds life-sciences companies. Comparable as a deep life-sciences specialist, though operating at vastly greater scale with proprietary company-creation model.
  • Atlas Venture: Early-stage life sciences venture firm that builds biotech companies from inception. Comparable as an early-stage specialist in the same life-sciences category Hopen targets.
  • MPM Capital: Biotech-focused venture firm investing across oncology and other therapeutic areas. Directly comparable life-sciences specialist, though significantly larger and more institutional.
  • OrbiMed: Healthcare-dedicated investment firm across venture, growth, and credit stages. Closely comparable sector focus on life sciences and healthcare, with far broader scale and product offerings.
  • ARCH Venture Partners: One of the most established US venture firms focused exclusively on life sciences and advanced technology, including biotech and healthcare. Highly comparable as a specialist life-sciences investor, though significantly larger and more established than Hopen.
  • Frazier Healthcare Partners: Healthcare-focused venture and growth firm investing across biopharma and medical devices. Same sector thesis as Hopen, with a multi-fund platform and longer operating history.

Regional players

  • BioEnterprise: Regional life-sciences commercialization organization supporting healthcare and biotech startups in the Midwest. Compares as a regionally focused life-sciences ecosystem participant, though structured more as a support organization than a pure VC.

Broad incumbents

  • Deerfield Management: Large healthcare investment firm spanning venture, public equities, and credit. Broad incumbent in the healthcare investment space Hopen targets, with overlapping life-sciences venture activity but a much wider mandate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Hopen Life Science Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hopen Life Science Ventures leadership team

Management profile

Number of profiles

Profiles1 record

Hopen Life Science Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hopen Life Science Ventures M&A and investment

M&A and investment

M&A

Investments12 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hopen Life Science Ventures

What does Hopen Life Science Ventures do?

Hopen Life Science Ventures is described as a venture capital firm investing in the life science and healthcare sectors. However, its public website is currently in a "Launching Soon" pre-launch state, with no fund products, portfolio, or investment vehicles currently listed or marketed. The site only offers a contact form for email list sign-ups.

When was Hopen Life Science Ventures founded?

Hopen Life Science Ventures was founded in 2008. It employs 1 to 10 people.

Where is Hopen Life Science Ventures based?

Hopen Life Science Ventures is headquartered in Grand Rapids, United States, in the North America region.

Who are Hopen Life Science Ventures's main competitors?

Direct peers on record are 5AM Ventures, Versant Ventures, Flagship Pioneering, Atlas Venture, MPM Capital, OrbiMed, ARCH Venture Partners and Frazier Healthcare Partners. BioEnterprise is listed as a regional player. Deerfield Management is listed as a broad incumbent.

Does Hopen Life Science Ventures have an API?

No public API is recorded for Hopen Life Science Ventures.

What industry is Hopen Life Science Ventures in?

Hopen Life Science Ventures's product category is Venture Capital / Life Science Investment. Its primary akta.pro industry code is FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed), with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsBjond Closes $3.25M Series A FinancingBjond, a care management platform provider, closed a $3.25M Series A financing led by Draper Triangle Ventures with participation from TriStar Technology Ventures and Hopen Life Science Ventures. The company will use the funds to accelerate implementing BjondHealth's latest version, which offers workflow automation and decision support tools.VC News DailyBjond Closes $3.25M in Series ABjond, a healthcare technology company, closed a $3.25 million Series A financing round led by Draper Triangle Ventures, with participation from TriStar Technology Ventures and Hopen Life Science Ventures. The company will use the funds to accelerate implementation of its BjondHealth platform, which provides workflow automation and decision support tools for healthcare payers and providers. Bjond has offices in Boston and Columbus and has attracted a payer and provider following for its care management solutions.FinSMEsTolera Therapeutics Closes $5.5M Series B-3 FinancingTolera Therapeutics closed a $5.5 million Series B-3 financing round led by Hopen Life Science Ventures. The company will use the funds to prepare for Phase 3 testing of TOL101, its lead clinical candidate, with an FDA Special Protocol Assessment planned.VC News DailyHopen Life Science Ventures Fund Hits $25MHopen Life Science Ventures announced an initial close of $25 million for its second life science venture capital fund based in Grand Rapids, Michigan. The fund aims to make 8-12 investments in early-stage life science companies that focus on innovative healthcare solutions. Fund II has already completed four investments, targeting companies with remarkable innovations in healthcare.